Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

Theratechnologies' novel cancer treatment granted additional patent protection

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

New telomerase inhibitors from Geron

Jan. 23, 1998

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

Jan. 23, 1998

Gastrimmune significantly increases survival in advanced colorectal cancer

Jan. 22, 1998

Korean researchers characterize new antimicrobial/cytotoxic compound of microbial origin

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026